Abbott's flat sales blamed on exchange rates
This article was originally published in Clinica
Abbott's laboratory business continues to be hit by currency effects - sales in the third quarter were flat, with low growth in the US and a decline in international sales. Excluding exchange rates effects, international sales rose 8%.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.